By vgreene, 19 January, 2021 The vaccines contain strands of messenger RNA inside of a special coating which helps protect the mRNA from breakdown helps it enter dendritic cells macrophages in lymph nodes near the injection site
By vgreene, 19 January, 2021 In contrast to most vaccines which use weakened or inactivated versions of the dz causing pathogen mRNA vaccines take advantage of the process that cells use to make proteins to trigger an immune response
By vgreene, 19 January, 2021 CDC encourages individuals to enroll in the agency s free smartphone tool called v safe that uses text messaging web surveys to provide personalized health check ins after pts receive a COVID 19 vaccination V safe also reminds pts to get their 2nd dose1
By vgreene, 19 January, 2021 Both mRNA COVID 19 vaccines and the Janssen vector based vaccine were tested in large clinical trials and have good safety profiles2
By vgreene, 19 January, 2021 CDC s Advisory Committee on Immunization Practices ACIP also reviews all safety data before recommending any COVID 19 vaccine for use FDA CDC will continue to monitor the safety of COVID 19 vaccines make sure even very rare side effects are identified1 2
By vgreene, 19 January, 2021 FDA carefully reviews all safety data from clinical trials authorizes emergency vaccine use only when the expected benefits outweigh potential risks2
By vgreene, 19 January, 2021 Many existing vaccines incl inactivated influenza vaccines can cause rare complications incl Guillain Barre syndrome GBS seizures unexplained death Public health experts view the risks as minuscule when considering the millions of people who are safely va
By vgreene, 19 January, 2021 Yes w rare exceptions The benefits of COVID 19 vaccination in preventing morbidity and mortality far exceed the risks of rare serious adverse events after vaccination CDC has concluded based on an ACIP review of benefit risk analyses1
